Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
. The review is devoted to the most important aspects of primary mixed dyslipidemia treatment in patients at high risk with concomitant metabolic comorbidities. Evidences for novel modern approaches regarding primary prevention of cardiovascular events among dyslipidemic patients are considered. Th...
Saved in:
Published in | Medychni perspektyvy Vol. 20; no. 2; pp. 54 - 62 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English Russian Ukrainian |
Published |
Dnipropetrovsk
Dnipro State Medical University
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!